Hypertension
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.aged 40 to 65 at the time of inclusion 2.systolic blood pressure between 130 mmHg and 159 mmHg at the time of inclusion 3.able to walk independently without the use of a walking aid 4.able to communicate, read and write in Japanese 5.owns an iPhone and can agree to carry it at all times during the study period 6.do not own a smartwatch, or if they do, are willing to consent to unpair their smartwatch from their iPhone during the study 7.can provide written consent to participate in the study of his/her own free will
Exclusion criteria
Exclusion criteria: 1.already exercising at least 3 days a week 2.prohibited from exercising by a physician for any reason 3.systolic blood pressure 160 mmHg or higher or diastolic blood pressure 100 mmHg or higher at the time of inclusion 4.already taking antihypertensive medication 5.diagnosed with angina 6.has experienced chest pain or shortness of breath during labor 7.has a history of syncope during exercise 8.has a history of arrhythmia or palpitations 9.has heart murmurs on auscultation 10.diagnosed with chronic kidney disease or diabetes mellitus. 11.diagnosed with secondary hypertension or suspected based on medical history. 12.judged by the investigator to be ineligible for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in systolic blood pressure from baseline to 8 weeks of app use | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in diastolic blood pressure from baseline to 8 weeks of app use Change in systolic blood pressure from baseline to 4 weeks of app use Change in diastolic blood pressure from baseline to 4 weeks of app use Change in body weight from baseline to 4 weeks of app use Change in body weight from baseline to 8 weeks of app use Correlation between the average number of successful weekly challenges and the change in systolic blood pressure. | — |
Countries
Japan
Contacts
Oita University Faculty of Medicine Department of Clinical Pharmacology and Therapeutics